https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-26 / Mol. Cancer 2006 Oct;5:49
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-26 / Mol. Cancer 2006 Oct;5:492006-10-26 00:00:002019-02-15 08:35:27Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-272006-10-23 00:00:002019-02-15 08:52:20In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-12 / Blood 2007 Feb;109(3):1165-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-12 / Blood 2007 Feb;109(3):1165-732006-10-12 00:00:002019-02-15 08:44:37Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-452006-10-10 00:00:002019-02-15 09:24:12Vaccination therapy in prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / APMIS 2006 Oct;114(10):731-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / APMIS 2006 Oct;114(10):731-432006-10-01 00:00:002006-10-01 00:00:00Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Nan Fang Yi Ke Da Xue Xue Bao 2006 Oct;26(10):1487-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Nan Fang Yi Ke Da Xue Xue Bao 2006 Oct;26(10):1487-902006-10-01 00:00:002006-10-01 00:00:00[Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-42006-10-01 00:00:002019-02-15 08:51:26Current status of immunotherapy in B cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-602006-10-01 00:00:002019-02-15 08:35:53[Clinical impact of locoregional hyperthermia in gynecological oncology]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-122006-10-01 00:00:002019-02-15 08:32:38Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
